NGS has helped fuel discovery and innovation in genetic engineering. But for demanding users, the power of today’s sequencing technology has surpassed our ability to accurately and reliably analyze the data produced. That’s because researchers working with stem cells and/or genetic engineering in fields like Neurology, Oncology, Hematology, or Infectious Disease often require the highest possible accuracy and reliability in their results. And the closer this research comes to clinical applications, the more stringent those criteria become.
TIGERQ offers a sample-to-analysis NGS solution made to accelerate your progress and publications.
At the heart of our state-of-the-art NGS pipelines is our proprietary next-generation analysis. We have designed it to answer all gene editing efficiency questions with the highest possible accuracy.
In this white paper, we describe the science behind our next-generation analysis and how your research can benefit from it.
• 98% Accurate gene editing quantification
• 10X Greater detection range
• 4X Lower error rate
• Targeted tagmentation and amplicon NGS
• Single nucleotide modification spectrum
• Affordable pricing with a one-week turnaround time
Essential Reading for any Researcher Working with
• Cancer diagnosis
• Immunology
• Reproductive health
• Clinical history
• Infectious disease
• Preclinical research
• Gene editing
• Stem cells
Download your Free Copy
Taking NGS to
the Next Level
An Introduction to Next Generation Analysis